{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:01:17Z","timestamp":1775142077996,"version":"3.50.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Late-onset Pompe disease (LOPD) is an autosomal-recessive metabolic myopathy caused by deficiency of the lysosomal enzyme Acid Alpha\u2014Glucosidase (GAA), leading to glycogen accumulation in proximal and axial muscles, and in the diaphragm. Enzyme Replacement Therapy (ERT) with recombinant GAA became available in 2006. Since then, several outcome measures have been investigated for the adequate follow-up of disease progression and treatment response, usually focusing on respiratory and motor function. Prognostic factors predicting outcome have not been identified till now.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> In this single Centre, prospective study, we evaluate the response to enzyme replacement therapy in 15 patients (7 males) with LOPD in different stages of disease, aged 49.4 \u00b1 16.1, followed-up for 15\u00a0years. Treatment response was measured by the 6-min walking test, vital capacity in supine and upright position, respiratory muscle strength, muscle MRI, manual muscle testing. We investigated the usefulness of Body Impedance Vectorial Analysis for serial body composition assessment.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Although most patients with LOPD benefit from long-term treatment, some secondary decline may occur after the first 3\u20135\u00a0years. Some nutritional (lower body mass index, higher fat free mass, higher phase angle) and disease parameters (higher creatinine and shorter disease duration at the beginning of treatment) seem to predict a better motor outcome. Lower Phase Angle, possibly reflecting loss of integrity of skeletal muscle membranes and thus treatment mis-targeting, seems to correlate with worse treatment response on long-term follow-up.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Body Impedance Vectorial Analysis is a fast, easily performed and cheap tool that may be able to predict long-term treatment response in patients with LOPD. Low Phase angle may serve as a marker of muscle quality and may be used to predict the response to a muscle-targeted intervention such as ERT, thus improving the identification of patients needing a closer follow-up due to higher fragility and risk of deterioration.<\/jats:p>","DOI":"10.3389\/fcell.2022.793566","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T15:40:58Z","timestamp":1645198858000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Bioimpedance Phase Angle as a Prognostic Tool in Late-Onset Pompe Disease: A Single-Centre Prospective Study With a 15-year Follow-Up"],"prefix":"10.3389","volume":"10","author":[{"given":"Sabrina","family":"Ravaglia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachele","family":"de Giuseppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Carlucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Jehne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia","family":"Crescimanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pichiecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosella","family":"Bazzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Cirio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enza Maria","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare","family":"Danesino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"De Filippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Tartara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hellas","family":"Cena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1164\/rccm.166.4.518","article-title":"ATS\/ERS Statement on Respiratory Muscle Testing","volume":"166","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10545-014-9728-1","article-title":"Effectiveness of Enzyme Replacement Therapy in Adults with Late-Onset Pompe Disease: Results from the NCS-LSD Cohort Study","volume":"37","author":"Anderson","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10526-5","article-title":"Clinical Efficacy of the Enzyme Replacement Therapy in Patients with Late-Onset Pompe Sisease: A Systematic Review and a Meta-Analysis","author":"Berli","year":"2021","journal-title":"J. Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/jep.12629","article-title":"Minimal Clinically Important Difference for Change in 6\u2010minute Walk Test Distance of Adults with Pathology: a Systematic Review","volume":"23","author":"Bohannon","year":"2017","journal-title":"J. Eval. Clin. Pract."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41430-018-0384-7","article-title":"Body Hydration Assessment Using Bioelectrical Impedance Vector Analysis in Neurologically Impaired Children","volume":"73","author":"Calcaterra","year":"2019","journal-title":"Eur. J. Clin. Nutr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.nmd.2011.06.748","article-title":"Whole-body Muscle MRI in 20 Patients Suffering from Late Onset Pompe Disease: Involvement Patterns","volume":"21","author":"Carlier","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ymgme.2016.12.004","article-title":"The Emerging Phenotype of Late-Onset Pompe Disease: A Systematic Literature Review","volume":"120","author":"Chan","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.3390\/jcm10214828","article-title":"A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease","volume":"10","author":"Dornelles","year":"2021","journal-title":"J. Clin. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1467-789X.2008.00546.x","article-title":"Effect of Body Mass index on the Outcome of Infections: a Systematic Review","volume":"10","author":"Falagas","year":"2009","journal-title":"Obes. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"76PMC4289085","DOI":"10.1038\/nm.3710","article-title":"Inducible Depletion of Satellite Cells in Adult, Sedentary Mice Impairs Muscle Regenerative Capacity without Affecting Sarcopenia","volume":"21","author":"Fry","year":"2015","journal-title":"Nat. Medpmcid"},{"key":"B10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41430-018-0159-1","article-title":"Phase Angle and Mortality: a Systematic Review","volume":"73","author":"Garlini","year":"2019","journal-title":"Eur. J. Clin. Nutr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1756PMC6946483","DOI":"10.1212\/WNL.0000000000008441","article-title":"Large Variation in Effects during 10 Years of Enzyme Therapy in Adults with Pompe Disease","volume":"93","author":"Harlaar","year":"2019","journal-title":"Neurology PMCID"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1212\/WNL.0000000000004711","article-title":"Long-term Benefit of Enzyme Replacement Therapy in Pompe Disease","volume":"89","author":"Kuperus","year":"2017","journal-title":"Neurology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1783PMC6035739","DOI":"10.1016\/j.ymthe.2018.04.025","article-title":"Therapeutic Benefit of Autophagy Modulation in Pompe Disease","volume":"26","author":"Lim","year":"2018","journal-title":"Mol. Therapy PMCID"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3548284","DOI":"10.1155\/2019\/3548284","article-title":"Assessment of Body Composition in Health and Disease Using Bioelectrical Impedance Analysis (BIA) and Dual Energy X-Ray Absorptiometry (DXA): A Critical Overview","volume":"2019","author":"Marra","year":"2019","journal-title":"Contrast Media Mol. Imaging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.clnu.2010.03.011","article-title":"Assessing Change in Body Composition in Children with Duchenne Muscular Dystrophy: Anthropometry and Bioelectrical Impedance Analysis versus Dual-Energy X-ray Absorptiometry","volume":"29","author":"Mok","year":"2010","journal-title":"Clin. Nutr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.nmd.2020.12.001","article-title":"Effect of Long Term Enzyme Replacement Therapy in Late Onset Pompe Disease: A Single-Centre Experience","volume":"31","author":"Papadimas","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"B27","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s12325-008-0086-y","article-title":"Enzyme Replacement Therapy in Severe Adult-Onset Glycogen Storage Disease Type II","volume":"25","author":"Ravaglia","year":"2008","journal-title":"Adv. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10545-010-9204-5","article-title":"Changes in Skeletal Muscle Qualities during Enzyme Replacement Therapy in Late-Onset Type II Glycogenosis: Temporal and Spatial Pattern of Mass vs. Strength Response","volume":"33","author":"Ravaglia","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10526-5","article-title":"Clinical Efficacy of the Enzyme Replacement Therapy in Patients with Late-Onset Pompe Disease: A Systematic Review and a Meta-Analysis","author":"Sarah","year":"2021","journal-title":"J. Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.dsx.2017.08.006","article-title":"Energy Expenditure, Body Composition, and Prevalence of Metabolic Disorders in Patients with Duchenne Muscular Dystrophy","volume":"12","author":"Saure","year":"2018","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00415-016-8219-8","article-title":"Survival and Long-Term Outcomes in Late-Onset Pompe Disease Following Alglucosidase Alfa Treatment: a Systematic Review and Meta-Analysis","volume":"264","author":"Schoser","year":"2017","journal-title":"J. Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1159\/000264655","article-title":"Foot and Ankle Strength Assessment Using Hand-Held Dynamometry: Reliability and Age-Related Differences","volume":"56","author":"Spink","year":"2010","journal-title":"Gerontology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1183\/09031936.02.02092001","article-title":"Physiological Responses to the 6-min Walk Test in Patients with Chronic Obstructive Pulmonary Disease","volume":"20","author":"Troosters","year":"2002","journal-title":"Eur. Respir. J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"48PMC4880056","DOI":"10.1016\/j.resp.2016.02.007","article-title":"Neuropathology in Respiratory-Related Motoneurons in Young Pompe (Gaa) Mice","volume":"227","author":"Turner","year":"2016","journal-title":"Respir. Physiol. Neurobiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.nmd.2008.11.007","article-title":"Rate of Disease Progression during Long-Term Follow-Up of Patients with Late-Onset Pompe Disease","volume":"19","author":"Van der Beek","year":"2009","journal-title":"Neuromuscul. Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.nmd.2010.09.011","article-title":"Where Do We Stand in Enzyme Replacement Therapy in Pompe's Disease?","volume":"20","author":"van der Ploeg","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/mus.21025","article-title":"Clinical Features of Late-Onset Pompe Disease: a Prospective Cohort Study","volume":"38","author":"Wokke","year":"2008","journal-title":"Muscle Nerve"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.793566\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T15:41:00Z","timestamp":1645198860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.793566\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":28,"alternative-id":["10.3389\/fcell.2022.793566"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2022.793566","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,18]]},"article-number":"793566"}}